What are the most common bacteria causing urinary tract infections (UTIs) in an adult patient with a complicated UTI?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Bacteria Causing Complicated UTIs in Adults

In adults with complicated UTIs, Escherichia coli remains the most common pathogen, but the microbial spectrum is significantly broader than in uncomplicated infections, with Klebsiella spp., Proteus spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. representing the other major causative organisms. 1

Primary Bacterial Pathogens in Complicated UTIs

The microbial landscape differs substantially from uncomplicated UTIs:

  • E. coli is the single most common organism, though it occurs proportionally less frequently than in uncomplicated UTIs 1, 2, 3

  • The following organisms constitute the expanded spectrum in complicated infections: 1

    • Klebsiella pneumoniae and other Klebsiella species
    • Proteus species (P. mirabilis, P. vulgaris)
    • Pseudomonas species (including P. aeruginosa)
    • Serratia species (S. marcescens)
    • Enterococcus species
  • Additional pathogens frequently isolated include: 4, 5

    • Staphylococcus aureus (both penicillinase and non-penicillinase producing)
    • Staphylococcus epidermidis
    • Enterobacter species
    • Morganella morganii
    • Anaerobic organisms (Bacteroides fragilis, Clostridium species, Peptostreptococcus species) in specific complicated scenarios

Key Distinguishing Features from Uncomplicated UTIs

Antimicrobial resistance is substantially more likely in complicated UTIs compared to uncomplicated infections. 1

  • E. coli strains isolated from complicated UTIs demonstrate fewer virulence characteristics but higher resistance rates than those from uncomplicated infections 1
  • Extended-spectrum β-lactamase (ESBL)-producing organisms are a particular concern in complicated UTIs 1
  • Multidrug-resistant uropathogens represent an increasingly important consideration in management 1

Clinical Context for Bacterial Spectrum

The broader microbial spectrum reflects the underlying host and anatomic factors:

  • Patients with structural/functional urinary tract abnormalities harbor more diverse organisms 1
  • Healthcare-associated infections increase the likelihood of resistant organisms 1
  • Catheter-associated UTIs approach 100% prevalence of bacteriuria with long-term catheterization, involving polymicrobial flora 1
  • Male patients with UTI (nearly always considered complicated) show higher rates of coagulase-negative staphylococci, gram-negative bacilli, and Enterococcus species 1

Practical Implications for Empiric Therapy

Always obtain urine culture and susceptibility testing before initiating therapy in complicated UTIs, as the expanded microbial spectrum and resistance patterns necessitate tailored antimicrobial selection. 1

  • Empiric therapy should cover the broader spectrum while awaiting culture results 1
  • Local resistance patterns must guide initial antibiotic selection 1
  • Initial therapy should be modified based on susceptibility results to prevent overtreatment and reduce selection pressure for resistant organisms 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Urinary Tract Infections with Significant Bacteriuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.